BioRad, Infometrix team up

PHILADELPHIA—Bio-Rad Laboratories and Infometrix announced a new informatics application called AnalyzeIt MVP
| 2 min read
PHILADELPHIA—Boasting a software integration by two parties that didn't meet face to face until two days before the unveiling of their new combined offering, Bio-Rad Laboratories Inc. and chemometrics specialist Infometrix announced at Pittcon 2006 last month a new informatics application called AnalyzeIt MVP. The software, an integration of Infometrix' Pirouette chemometrics technology for multivariate processing and Bio-Rad's KnowItAll informatics system, promises to allow researchers methods to better analyze large spectral, chromatographic, chemical and biological data sets especially in the area of metabolomics.
Once work began, Banik says, the work flowed smoothly due to the similar philosophies of the two companies. "We heard from some of our customers that Infometrix had the reputation as the premier chemometrics company," he notes. "To be able to do this quickly and to create this new tool showed us that it is a reputation they deserve."
To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

About the Author

Related Topics

Published In

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Bands of diffused color illustrating pigment separation.
Discover how supercritical fluids expand chromatographic capabilities across diverse analytical challenges.
A 3D molecular visualization of antibody-like protein structures with attached yellow payloads floating against a dark, space-like background.
Evolving approaches to conjugation chemistry and linker–payload design are helping address persistent challenges in bioconjugate development.
Fluorescent-style illustration of spherical embryonic stem cells clustered together against a dark background.
Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes. 
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue